Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

• Główni autorzy: María José Contreras-Gómez (Autor), José R. W. Martinez (Autor), Lina Rivas (Autor), Roberto Riquelme-Neira (Autor), Juan A. Ugalde (Autor), Aniela Wozniak (Autor), Patricia García (Autor), José M. Munita (Autor), Jorge Olivares-Pacheco (Autor), Manuel Alcalde-Rico (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is one of the pathogens that urgently needs new drugs and new alternatives for its control. The primary strategy to combat this bacterium is combining treatments of beta-lactam with a beta-lactamase inhibitor. The most used combinations against P. a...